Literature DB >> 27258139

Biodegradable Oxamide-Phenylene-Based Mesoporous Organosilica Nanoparticles with Unprecedented Drug Payloads for Delivery in Cells.

Jonas G Croissant1,2, Yevhen Fatieiev1, Khachatur Julfakyan1, Jie Lu3, Abdul-Hamid Emwas4, Dalaver H Anjum4, Haneen Omar1, Fuyuhiko Tamanoi3, Jeffrey I Zink2, Niveen M Khashab5.   

Abstract

We describe biodegradable mesoporous hybrid nanoparticles (NPs) in the presence of proteins and their applications for drug delivery. We synthesized oxamide phenylene-based mesoporous organosilica nanoparticles (MON) in the absence of a silica source which had remarkably high organic content and high surface areas. Oxamide functions provided biodegradability in the presence of trypsin model proteins. MON displayed exceptionally high payloads of hydrophilic and hydrophobic drugs (up to 84 wt %), and a unique zero premature leakage without the pore capping, unlike mesoporous silica. MON were biocompatible and internalized into cancer cells for drug delivery.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biodegradable; bridged silsesquioxanes; drug delivery; enzymes; nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 27258139     DOI: 10.1002/chem.201601714

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  6 in total

1.  Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery.

Authors:  Seyyed Pouya Hadipour Moghaddam; Mostafa Yazdimamaghani; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2018-04-19       Impact factor: 9.776

2.  Redox-Responsive Polysulfide-Based Biodegradable Organosilica Nanoparticles for Delivery of Bioactive Agents.

Authors:  Seyyed Pouya Hadipour Moghaddam; Jiban Saikia; Mostafa Yazdimamaghani; Hamidreza Ghandehari
Journal:  ACS Appl Mater Interfaces       Date:  2017-06-13       Impact factor: 9.229

3.  Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug.

Authors:  Ngoc Xuan Dat Mai; Albane Birault; Kotaro Matsumoto; Hanh Kieu Thi Ta; Soontaree Grace Intasa-Ard; Kendall Morrison; Phan Bach Thang; Tan Le Hoang Doan; Fuyuhiko Tamanoi
Journal:  ChemMedChem       Date:  2020-02-11       Impact factor: 3.466

4.  Cancer cell membrane-modified biodegradable mesoporous silica nanocarriers for berberine therapy of liver cancer.

Authors:  Juan Yue; Zheng Wang; Dan Shao; Zhimin Chang; Rui Hu; Li Li; Shi-Zhong Luo; Wen-Fei Dong
Journal:  RSC Adv       Date:  2018-12-04       Impact factor: 4.036

5.  Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.

Authors:  Binh Thanh Vu; Sophia Allaf Shahin; Jonas Croissant; Yevhen Fatieiev; Kotaro Matsumoto; Tan Le-Hoang Doan; Tammy Yik; Shirleen Simargi; Altagracia Conteras; Laura Ratliff; Chiara Mauriello Jimenez; Laurence Raehm; Niveen Khashab; Jean-Olivier Durand; Carlotta Glackin; Fuyuhiko Tamanoi
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

Review 6.  Influence of the Surface Functionalization on the Fate and Performance of Mesoporous Silica Nanoparticles.

Authors:  Miguel Gisbert-Garzarán; María Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2020-05-09       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.